The principal objective of this project is to identify genes/SNPs associated with combined familial hyperlipidemia (CFH) in order to develop a genetic "score" factor for diagnostic or predictive purposes. A secondary objective is to identify specific genes/SNPs related to the cardiovascular risk factors characteristic of CFH (hypercholesterolemia, hypertriglyceridemia, hypertension and obesity), compare them with the CFH-related genes/SNPs, and assess all potential interactions between them. The proposed methodology is to review genome-wide association studies and use OpenArray technology to identify the SNPs associated with three cardiovascular risk factors --hyperlipidemia, arterial hypertension, and obesity-- in 5000 subjects, including 1000 patients with CHF, 1000 patients with hypertension, 1000 obese patients, 1000 healthy controls, and 1000 individuals from the general population. Statistical analysis of the genetic results will determine associations, interactions, and the predictive capacity of the SNPs studied. A "genetic score" will be developed to improve CHF diagnosis.
The principal objective of this project is to identify genes/SNPs associated with combined familial hyperlipidemia (CFH) in order to develop a genetic "score" factor for diagnostic or predictive purposes. A secondary objective is to identify specific genes/SNPs related to the cardiovascular risk factors characteristic of CFH (hypercholesterolemia, hypertriglyceridemia, hypertension and obesity), compare them with the CFH-related genes/SNPs, and assess all potential interactions between them. The proposed methodology is to review genome-wide association studies and use OpenArray technology to identify the SNPs associated with three cardiovascular risk factors --hyperlipidemia, arterial hypertension, and obesity-- in 5000 subjects, including 1000 patients with CHF, 1000 patients with hypertension, 1000 obese patients, 1000 healthy controls, and 1000 individuals from the general population. Statistical analysis of the genetic results will determine associations, interactions, and the predictive capacity of the SNPs studied. A "genetic score" will be developed to improve CHF diagnosis.
Fondo de Investigaciones Sanitarias (FIS) - Instituto Carlos III
Número proyecto: PI13/02507
69.575,00 €
2013
2013
2016
Instituto Aragonés de Ciencias de la Salud, Hospital Miguel Servet, Zaragoza
IMIM (Institut Hospital del Mar d’Investigacions Mèdiques), Barcelona
IMIM (Institut Hospital del Mar d’Investigacions Mèdiques), Barcelona